Celgene and bluebird bio have agreed to co-commercialize and co-promote an investigational cell therapy treatment known as bb2121 in the United States.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.